Astoria Portfolio Advisors LLC. Has $633,000 Position in UnitedHealth Group Incorporated $UNH

Astoria Portfolio Advisors LLC. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,030 shares of the healthcare conglomerate’s stock after selling 611 shares during the quarter. Astoria Portfolio Advisors LLC.’s holdings in UnitedHealth Group were worth $633,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Citizens National Bank Trust Department raised its position in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after buying an additional 170 shares during the last quarter. Caitlin John LLC increased its position in shares of UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares during the last quarter. Triumph Capital Management acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $1,324,000. Wealth Effects LLC grew its stake in shares of UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after buying an additional 591 shares in the last quarter. Finally, Arlington Partners LLC bought a new position in shares of UnitedHealth Group in the second quarter valued at $2,229,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on UNH. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Barclays boosted their target price on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a report on Thursday. Piper Sandler reduced their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Finally, Sanford C. Bernstein boosted their price target on UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and a consensus price target of $383.09.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $354.30 on Monday. The stock has a fifty day moving average price of $318.21 and a 200-day moving average price of $348.08. The company has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.